Blood Journal
Leading the way in experimental and clinical research in hematology

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

  1. Helmut Gadner1,
  2. Milen Minkov1,
  3. Nicole Grois1,
  4. Ulrike Pötschger1,
  5. Elfriede Thiem1,
  6. Maurizio Aricò2,
  7. Itziar Astigarraga3,
  8. Jorge Braier4,
  9. Jean Donadieu5,
  10. Jan-Inge Henter6,
  11. Gritta Janka-Schaub7,
  12. Kenneth L. McClain8,
  13. Sheila Weitzman9,
  14. Kevin Windebank10, and
  15. Stephan Ladisch11,
  16. for the Histiocyte Society
  1. 1Children’s Cancer Research Institute and St. Anna Children’s Hospital, Vienna, Austria;
  2. 2Department of Hematology-Oncology, University Children’s Hospital, Florence, Italy;
  3. 3Hospital Universitario Cruces, Bilbao, Spain;
  4. 4Hospital Nacional de Pediatria J. Garrahan, Buenos Aires, Argentina;
  5. 5Hospital Trousseau, Paris, France;
  6. 6Childhood Cancer Research Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;
  7. 7Department of Hematology and Oncology, University Medical Center, Hamburg, Germany;
  8. 8Texas Children’s Cancer and Hematology Centers, Houston, TX;
  9. 9Hospital for Sick Children, Division of Hematology/Oncology, Toronto, Ontario, Canada;
  10. 10Newcastle University, Newcastle, United Kingdom; and
  11. 11Children’s Research Institute, Children’s National Medical Center, Washington DC
PDF Container